Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin for Chronic Productive Cough in COPD
NCT01071161Phase 3Completed
- Sponsor
- Isala
- Start
- Sep 2009
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) and chronic bronchitis (CB) comparing Azithromycin with Placebo (2 arms). Primary endpoint: Leicester Cough Questionnaire at 18 weeks. Started Sep 2009; status: completed.
02
Drugs
azithromycin
03
Conditions
chronic obstructive pulmonary disease (COPD)chronic bronchitis (CB)
Beyond the preview
Go deeper on NCT01071161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01071161.